Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like GST rates: TVs, ACs, refrigerators to get costlier after 1 July GST rollout May 19, 2017 RBI unlikely to dictate banks’ haircuts on bad loans: S&P May 31, 2017 Perception Robotics, OptoForce and On Robot announce merger into OnRobot June 11, 2018